Get the Stockscreener App
156.32
1.45%
-1.725
Natera Inc stock is traded at $156.32, with a volume of 891.22K.
It is down -1.45% in the last 24 hours and up +3.20% over the past month.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
See More
Previous Close:
$158.05
Open:
$157.5
24h Volume:
891.22K
Relative Volume:
0.55
Market Cap:
$21.34B
Revenue:
$1.53B
Net Income/Loss:
$-214.69M
P/E Ratio:
-88.82
EPS:
-1.76
Net Cash Flow:
$-43.68M
1W Performance:
+1.59%
1M Performance:
+3.20%
6M Performance:
-7.17%
1Y Performance:
+41.44%
1-Day Range:
$153.93
$157.50
1-Week Range:
$153.93
$165.91
52-Week Range:
$92.14
$183.00
Natera Inc Stock (NTRA) Company Profile
Name
Natera Inc
Sector
Industry
Phone
650-249-9090
Address
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
156.29 | 20.82B | 1.53B | -214.69M | -43.68M | -1.76 |
|
TMO
Thermo Fisher Scientific Inc
|
403.42 | 151.18B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
190.40 | 134.17B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
515.00 | 40.60B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
111.87 | 31.27B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
140.19 | 23.88B | 15.50B | 1.33B | 2.16B | 7.34 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-13-25 | Initiated | RBC Capital Mkts | Outperform |
| Jan-23-25 | Initiated | Barclays | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-08-24 | Resumed | Craig Hallum | Buy |
| Feb-20-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-29-23 | Reiterated | BTIG Research | Buy |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Nov-13-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| May-05-23 | Initiated | UBS | Buy |
| Jan-18-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Mar-08-22 | Initiated | Goldman | Buy |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-15-21 | Initiated | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Wells Fargo | Overweight |
| Jan-28-21 | Initiated | Truist | Buy |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Sep-28-20 | Initiated | Morgan Stanley | Overweight |
| Sep-17-20 | Initiated | SVB Leerink | Outperform |
| Jun-10-20 | Resumed | Piper Sandler | Overweight |
| May-07-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-05-18 | Initiated | JP Morgan | Neutral |
| Jul-05-18 | Reiterated | Piper Jaffray | Overweight |
| Aug-07-17 | Reiterated | Morgan Stanley | Overweight |
| Nov-10-16 | Reiterated | The Benchmark Company | Buy |
| May-23-16 | Reiterated | The Benchmark Company | Buy |
| May-11-16 | Reiterated | The Benchmark Company | Buy |
| Apr-19-16 | Initiated | The Benchmark Company | Buy |
| Sep-28-15 | Upgrade | Wedbush | Neutral → Outperform |
| Aug-14-15 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-04-15 | Initiated | Robert W. Baird | Outperform |
| Jul-27-15 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-27-15 | Initiated | Piper Jaffray | Overweight |
| Jul-27-15 | Initiated | Wedbush | Neutral |
View All
Natera Inc Stock (NTRA) Latest News
Natera Inc (NTRA) Shares Up 3.07% on May 27 - GuruFocus
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today - Benzinga
When the Price of (NTRA) Talks, People Listen - news.stocktradersdaily.com
Natera Reaches 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily
Natera to Present over 25 Signatera™ Studies at 2025 ASCO Annual Meeting | NTRA Stock News - GuruFocus
Natera to Present over 25 Signatera™ Studies at 2025 ASCO Annual Meeting - Yahoo Finance
Natera raises 2025 revenue outlook to $1.94B-$2.02B with 26% growth target - MSN
Transcript : Natera, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2025, May-21-2025 10 - marketscreener.com
Natera (NTRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Stocks Showing Rising Market Leadership: Natera Earns 82 RS Rating - Investor's Business Daily
There's Reason For Concern Over Natera, Inc.'s (NASDAQ:NTRA) Price - simplywall.st
Natera (NASDAQ:NTRA) Rating Lowered to “Sell” at StockNews.com - Defense World
Natera (NASDAQ:NTRA) Stock Price Expected to Rise, Piper Sandler Analyst Says - Defense World
Natera: The Clues In Q1 Earnings (NASDAQ:NTRA) - Seeking Alpha
NTRA: Piper Sandler Raises Price Target for Natera | NTRA Stock News - GuruFocus
NTRA Price Target Increased by Piper Sandler After Quarterly Res - GuruFocus
Natera, Inc. (NTRA): A Bull Case Theory - MSN
Trend Tracker for (NTRA) - news.stocktradersdaily.com
Natera Inc. Shines in Earnings Call with Strong Growth - TipRanks
Here's How Much $100 Invested In Natera 5 Years Ago Would Be Worth Today - Benzinga
Natera’s Strong Market Position and Growth Potential Drive Buy Rating and Increased Price Target - TipRanks
Natera’s Strong Q1 2025 Performance and Strategic Growth Justify Buy Rating - TipRanks
Natera (NASDAQ:NTRA) Price Target Raised to $218.00 - Defense World
Natera (NASDAQ:NTRA) Upgraded at StockNews.com - Defense World
Natera price target raised to $195 from $190 at BTIG - MSN
Barclays Raises Natera (NASDAQ:NTRA) Price Target to $190.00 - Defense World
Natera, Inc. (NASDAQ:NTRA) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - Yahoo
UBS Raises Natera (NTRA) Price Target to $218, Maintains Buy Rat - GuruFocus
Natera First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Natera, Inc. (NASDAQ:NTRA) Q1 2025 Earnings Call Transcript - Insider Monkey
RBC Capital Remains a Buy on Natera (NTRA) - The Globe and Mail
NTRA Price Target Increased as Natera Achieves Record Growth | N - GuruFocus
NTRA: Barclays Raises Price Target for Natera | NTRA Stock News - GuruFocus
Natera’s Strong Performance and Growth Potential Justifies Buy Rating - TipRanks
Cathie Wood’s ARK buys Shopify, Illumina stock; sells Palantir, Natera - Investing.com
Natera Shares Dip Amid Profitability Concerns - TipRanks
RBC maintains Outperform on Natera stock, price target at $251 - Investing.com
Natera stock price target raised to $200 at TD Cowen - Investing.com
RBC maintains Outperform on Natera stock, price target at $251 By Investing.com - Investing.com India
NTRA: TD Cowen Increases Price Target on Strong Performance | NT - GuruFocus
NTRA Reports Strong Q1 Revenue Exceeding Expectations | NTRA Sto - GuruFocus
NTRA: TD Cowen Increases Price Target on Strong Performance | NTRA Stock News - GuruFocus
8 Analysts Have This To Say About Natera - Benzinga
NTRA Stock Sees Price Target Increase by Barclays to $190 | NTRA Stock News - GuruFocus
Natera Q1 2025 slides: 37% revenue growth drives raised guidance By Investing.com - Investing.com Nigeria
Natera, Inc. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire
Natera Inc (NTRA) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Raised Guidance - Yahoo Finance
Natera Inc (NTRA) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Raised Guidance By GuruFocus - Investing.com Canada
Natera (NTRA) Reports Strong Q1 2025 Growth and Raises Revenue G - GuruFocus
Natera Inc. Reports Strong Q1 2025 Financial Growth - TipRanks
Natera Inc Stock (NTRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Natera Inc Stock (NTRA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sheena Jonathan | CO-FOUNDER |
May 12 '25 |
Sale |
158.26 |
3,000 |
474,766 |
38,782 |
| Chapman Steven Leonard | CEO AND PRESIDENT |
May 01 '25 |
Sale |
150.10 |
6,980 |
1,047,702 |
185,182 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
May 01 '25 |
Sale |
150.12 |
3,000 |
450,353 |
136,205 |
| Marcus Gail Boxer | Director |
May 01 '25 |
Option Exercise |
24.42 |
4,000 |
97,680 |
13,704 |
| Marcus Gail Boxer | Director |
May 01 '25 |
Sale |
151.61 |
4,000 |
606,433 |
9,704 |
0.20%
0.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):